Bio-IT World News
YouTube Facebook LinkedIn TwitterInstagram rss
a-divisiion-of-chi
  • Subscribe
  • News
    • Latest News
    • View Press Releases
    • Post a Press Release
    • Reprint Articles
  • Podcast
  • Advertise
    • Media Kit
    • Digital Advertising
    • Lead Generation
    • Editorial Calendar
    • Webinars
    • Whitepapers
    • Podcasts
    • View Press Releases
    • Post a Press Release
  • Free Downloads
    • Whitepapers
    • Podcasts
    • Webinars
    • Inside eBooks
  • Events
    • Webinars
    • Industry Events
    • IT Conferences
    • Bio-IT World Expo
    • Bio-IT World Expo Europe
  • About Us
    • Editorial Profile
    • Editorial Calender
    • Contact Us
    • Submit a story
    • Innovative Practices Awards
    • Linking Policy
  • Bio-IT World Expo
    • Bio-IT World Boston
    • Bio-IT World Europe
 
 
 
 
  • Watson-Marlow Fluid Technology Solutions and the National Institute for Bioprocessing Research and Training partner for biopharma training programme

    May 17, 2022, 15:42 PM by
    Watson-Marlow Fluid Technology Solutions (WMFTS) today announces it has partnered with the National Institute of Bioprocessing Research and Training (NIBRT) to develop and deliver a combined in-person and online global biopharma training programme for employees.
    Full story
  • X-Therma organ preservation technology granted FDA breakthrough device status

    May 17, 2022, 15:42 PM by
    Full story
  • PubMed Research Workflows Made Easier with PubHive Navigator

    May 17, 2022, 15:42 PM by
    New Google Chrome Browser extension simplifies research workflows for corporate life science teams that use PubMed and subscribe to PubHive’s cloud software platform
    Full story
  • ADC Technology: A Premier Institution of Antibody-Drug Conjugates Development

    May 17, 2022, 15:42 PM by
    ADC Technology releases a wide range of one-stop services related to ADC development such as antibody selection/modification, ADC payload and linker development, ADC conjugation, and ADC characterization and preclinical evaluation to help partners win the race of ADC research.
    Full story
  • Benefits of Stable Isotope Labelling in Biochemistry Research

    May 17, 2022, 15:42 PM by
    Stable isotope labeling is a powerful technique with promising applications.
    Full story
  • PROTAC-based Methods as Traditional PROTAC Protein Degradation Technology Alternatives

    May 17, 2022, 15:42 PM by
    Many emerging PROTAC-based technologies such as RNA-PROTACs and Photoswitchable PROTACs have expanded the scope of PROTAC development, providing more feasible potential strategies for the clinical treatment of related diseases.
    Full story
  • BOC Sciences Announces Featured PROTAC Design Services to Meet New Drug Discovery Goals

    May 17, 2022, 15:42 PM by
    BOC Sciences announced featured PROTAC design services to customers around the world to meet new drug discovery goals.
    Full story
  • Chemical Synthesis of Peptide Drug with Solid-Phase Methodology

    May 17, 2022, 15:42 PM by
    Peptide plays a key role in basic biochemical and physiological processes, and it is essential to many aspects of biomedical research, especially when the pharmaceutical industry continues to apply new drug candidates in the biological field. Therefore, rapid, efficient, and reliable methodology for the chemical synthesis of peptide drugs is of utmost interest in chemical biology research.
    Full story
  • Total Peptide Library: More Flexible and Productive

    May 17, 2022, 15:42 PM by
    Since the peptide library provides a powerful tool for drug development, protein-protein interactions, and other biochemical as well as pharmaceutical applications, the total peptide library becomes a productive tool as it enjoys higher stability because of the special structure of the peptide bond. Additionally, its construction cycle is relatively short compared with traditional peptide library construction technologies, accelerating the development of peptides drugs.
    Full story
  • New programme celebrates ChargePoint Technology's role in COVID-19 vaccine rollout

    May 17, 2022, 15:42 PM by
    Full story
  • New Release of Genedata Imagence Advances AI-powered HCS Image Analysis

    May 17, 2022, 15:42 PM by
    Genedata Imagence 5.0 industrializes the analysis of imaging assays across R&D organizations with advanced data QC workflows and scalable, flexible deployment options.
    Full story
  • New BHM® Anti-Viral Nasal Spray launches in Singapore

    May 17, 2022, 15:42 PM by
    Birmingham Biotech Ltd, an innovator in diagnostic tests, protective nasal sprays and mobile medical facilities, today announces the Singapore launch of its latest technology, BHM® Anti-Viral Nasal Spray, an easy-to-use nasal device with a unique patented formulation, Norizite™, designed to help prevent infection from the inhalation of airborne viruses within the nasal passages. The product will be available in Singapore from 1st May.
    Full story
  • AARDEX® Group adds etectRx to their MEMS® Adherence Hardware ecosystem

    May 17, 2022, 15:42 PM by
    AARDEX® Group adds etectRx to their MEMS® Adherence Hardware ecosystem The partnership sees the integration of AARDEX’s adherence analytics software with etectRx’s ingestible adherence sensor Liege, Belgium (APRIL 28th, 2022) – Belgium-based AARDEX® Group, the leader in measuring and managing medication adherence in clinical trials today announced a strategic partnership with etectRx, Inc. This new collaboration combines etectRx’s ingestible event marker, the ID-Cap™ System, and AARDEX® Group’s MEMS® Adherence Software (MEMS AS®) to track medication-taking behaviors. Together, they provide a holistic, objective, and precise method to measure and manage adherence to solid form dose medications.
    Full story
  • Royal seal of approval for Wales-based resin manufacturer Purolite

    May 17, 2022, 15:42 PM by
    Purolite, an Ecolab company and leading manufacturer of synthetic and agarose-based resins used in the bioprocessing industry, has been awarded the prestigious Queen’s Award for Enterprise in the International Trade category.
    Full story
  • CD Formulation Enriches Its Supply of Active Pharmaceutical Ingredient Excipients

    May 17, 2022, 15:42 PM by
    Continuing to be a trust-worthy CRO company for drug formulation and development, CD Formulation recently announces the enrichment of its active pharmaceutical ingredient excipient offerings. Now a number of API excipients are readily obtainable at CD Formulation, including Cetrorelix Acetate, Fondaparinux Sodium, Calcitriol, Vitamine D3, Tirofiban Hydrochloride, Eptifibatide, Ferric Ammonium Citrate, Calcipotriol API, Calcium Orotate, Meglumine, Obeticholic Acid, Potassium Magnesium Citrate and Magnesium Oxide.
    Full story
  • Adsorptive Polymers Are Now Available at Alfa Chemistry for Applications in Water Treatment, Medicine, Health Care, and Machine Processing

    May 17, 2022, 15:42 PM by
    Full story
  • Alfa Chemistry Launches Heat Stabilizers for PVC Industry

    May 17, 2022, 15:42 PM by
    Full story
  • Biopharma PEG Develops PEG Derivatives for ADCs Development

    May 17, 2022, 15:42 PM by
    Biopharma PEG leapts at the opportunity to develop various high purity PEG derivatives used as ADC linkers.
    Full story
  • 1upHealth Unveils Data Conversion App.

    May 17, 2022, 15:42 PM by
    Good afternoon, all -- 1upHealth, an intelligent health data platform with over 10,000 clinical and payer endpoints, today unveiled SQL on FHIR to streamline access to and make FHIR healthcare data computable to help organizations discover analytical insights and create compelling visualizations. SQL on FHIR allows healthcare organizations to convert FHIR data into a form that is easily searchable for specifics such as a patient’s observations, vital signs, and smoking status. This new platform is the next phase of 1upHealth’s mission to solve healthcare’s biggest data challenges, including helping organizations convert legacy claims and clinical data into clean, uniform FHIR. If interested in learning more about SQL on FHIR, I am happy to connect you with FHIR expert Joe Gagnon, CEO of 1upHealth, and/or a health plan executive to discuss the following: • Why SQL on FHIR fills the market gap for data conversion and will further aid healthcare organizations to perform at their highest levels • Strategies for organizations to enable FHIR analytics to reduce cost and improve operating models, quality metrics, and outcomes • The urgency to convert FHIR into searchable metrics with interoperability regulations looming and how this will help organizations further track and improve population health and SDoH The full release is included above. Please let me know if you have any questions or requests. Thanks! Anisa
    Full story
  • Samsung Biologics Reports First Quarter 2022 Financial Results

    May 17, 2022, 15:42 PM by
    Full story
  • «
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138 (current)
  • 139
  • 140
  • »
 
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@healthtech.com

Life Science Portals

Biological Therapeutic Products

Biomarkers & Diagnostics

Biopharma Strategy

Bioprocess & Manufacturing

Chemistry

Clinical Trials &
Translational Medicine

Drug & Device Safety

Drug Discovery & Development

Drug Targets

Healthcare

IT, AI, ML & Informatics

Technology & Tools For
Life Science

Therapeutic Indications

Venture, Innovation & Partnering

CHI Divisions

Conferences

Reports & Market Research

Barnett Educational Services

News & Advertising

Professional Services

Corporate Information

Cambridge Innovation
Institute

Executive Team

Testimonials

Mailing List

Careers


Request Information

Privacy Policy